COVID-19 Vaccines
Types of COVID-19 vaccines in the US, including those approved by the FDA under Emergency Use Authorization, as well as other investigational products currently in Phase 3 clinical trials.
Types of COVID-19 vaccines in the US, including those approved by the FDA under Emergency Use Authorization, as well as other investigational products currently in Phase 3 clinical trials.
As of April 5, 2022, CDC Nowcast data reported that the BA.2 subvariant accounted for more than 50% of cases in all US states and territories.
Prevalence of discrimination was reported to be higher among all racial/ethnic minorities than among White participants; those who identify as Asian or American Indian/Alaska Native were most likely to have experienced hostile behavior.
EDP-235 is currently being examined in a first-in-human phase 1 trial to assess safety, tolerability, and pharmacokinetics.
Researchers sought to assess the safety, tolerability, and immunogenicity of a novel pneumococcal conjugate vaccine (V114) in patients at risk for pneumococcal disease.
The researchers assessed the efficacy and safety of sequential mechanical ventilation in the treatment of tuberculosis with respiratory failure.
Previously, the initial loading dose of Nuzyra for CABP was administered only by IV infusion.
Results showed both trials of leronlimab did not meet primary or secondary endpoints.
Critically ill patients hospitalized with COVID-19 — particularly those who develop ARDS — may also experience an opportunistic aspergillosis superinfection.